Celldex Therapeutics to Present at Jefferies Healthcare Conference
2023年6月2日 - 9:01PM
Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that
management will participate in a fireside chat at the Jefferies
Healthcare Conference on Wednesday, June 7th at 9:00 am ET. A
webcast of the presentation will be available on the "Events &
Presentations" page of the "Investors & Media" section of the
Celldex website. A replay will be available for 90 days following
the event.
About Celldex Therapeutics, Inc.Celldex is a
clinical stage biotechnology company dedicated to developing
monoclonal and bispecific antibodies that address devastating
diseases for which available treatments are inadequate. Our
pipeline includes antibody-based therapeutics which have the
ability to engage the human immune system and/or directly affect
critical pathways to improve the lives of patients with
inflammatory diseases and many forms of cancer. Visit
www.celldex.com.
Company ContactSarah CavanaughSenior Vice
President, Corporate Affairs & Administration(508)
864-8337scavanaugh@celldex.com
Patrick TillMeru Advisors(484)
788-8560ptill@meruadvisors.com
Celldex Therapeutics (NASDAQ:CLDX)
過去 株価チャート
から 4 2024 まで 5 2024
Celldex Therapeutics (NASDAQ:CLDX)
過去 株価チャート
から 5 2023 まで 5 2024